FEMASYS INC (FEMY)
$3.30+$0.51 (+18.24%) Today
Latest FEMY Insider Trades
Jeremy Alexander Sipos - OfficerOpen-market purchase$10K
Jeremy Alexander Sipos - Officer
John Charles Canning - Officer
Dov Elefant - Officer
Kenneth D. Eichenbaum - Director
Alistair Milnes - DirectorFemasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 4 | 38,750 | $124K |
| Grant or award | 13 | 87,270 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
26 Form 4 filings on record, the earliest from Jun 23, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kenneth D. Eichenbaum - Director | Grant or award | Stock Option (Right to Buy) | 880 | $0.00 | - | |
| Edward R. Uzialko - Director | Grant or award | Stock Option (Right to Buy) | 880 | $0.00 | - | |
| Alistair Milnes - Director | Grant or award | Stock Option (Right to Buy) | 880 | $0.00 | - | |
| Charles Larsen - Director | Grant or award | Stock Option (Right to Buy) | 880 | $0.00 | - | |
| Jeffrey Gerald Mifek - Officer | Grant or award | Stock Option (Right to Buy) | 6,250 | $0.00 | - | |
| Jeremy Alexander Sipos - Officer | Open-market purchase | Common Stock | 3,125 | $3.20 | $10K | |
| Jeremy Alexander Sipos - Officer | Grant or award | Common Stock Purchase Warrant | 3,125 | - | - | |
| Jeremy Alexander Sipos - Officer | Grant or award | Common Stock Purchase Warrant (Milestone) | 3,125 | - | - | |
| John Charles Canning - Officer | Open-market purchase | Common Stock | 4,375 | $3.20 | $14K | |
| John Charles Canning - Officer | Grant or award | Common Stock Purchase Warrant | 4,375 | - | - | |
| John Charles Canning - Officer | Grant or award | Common Stock Purchase Warrant (Milestone) | 4,375 | - | - | |
| Dov Elefant - Officer | Open-market purchase | Common Stock | 15,625 | $3.20 | $50K | |
| Dov Elefant - Officer | Grant or award | Common Stock Purchase Warrant | 15,625 | - | - | |
| Dov Elefant - Officer | Grant or award | Common Stock Purchase Warrant (Milestone) | 15,625 | - | - | |
| Kathy Lee-Sepsick - Officer | Open-market purchase | Common Stock | 15,625 | $3.20 | $50K | |
| Kathy Lee-Sepsick - Officer | Grant or award | Common Stock Purchase Warrant | 15,625 | - | - | |
| Kathy Lee-Sepsick - Officer | Grant or award | Common Stock Purchase Warrant (Milestone) | 15,625 | - | - | |
| John Charles Canning - Officer | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| Kathy Lee-Sepsick - Officer | Grant or award | Series D-1 Warrants | 68,244 | - | - | |
| Dov Elefant - Officer | Grant or award | Series D-1 Warrants | 34,122 | - | - | |
| Kenneth D. Eichenbaum | Grant or award | Series D-1 Warrants | 102,366 | - | - | |
| Charles Larsen | Grant or award | Series D-1 Warrants | 34,122 | - | - | |
| Kenneth D. Eichenbaum | Grant or award | Stock Option (Right to Buy) | 35,200 | $0.00 | - | |
| Kathy Lee-Sepsick - Officer | Grant or award | Restricted Stock Units | 447,000 | $0.00 | - | |
| Kathy Lee-Sepsick - Officer | Grant or award | Restricted Stock Units | 282,000 | $0.00 | - | |
| Dov Elefant - Officer | Grant or award | Restricted Stock Units | 173,000 | $0.00 | - | |
| Dov Elefant - Officer | Grant or award | Restricted Stock Units | 169,000 | $0.00 | - | |
| Jeremy Alexander Sipos - Officer | Grant or award | Restricted Stock Units | 80,000 | $0.00 | - | |
| Kathy Lee-Sepsick - Officer | Other | Senior Secured Convertible Notes | 0 | - | - | |
| Kathy Lee-Sepsick - Officer | Other | Series A-1 Warrants | 68,244 | - | - | |
| Kathy Lee-Sepsick - Officer | Other | Series B-1 Warrants | 68,244 | - | - | |
| Kathy Lee-Sepsick - Officer | Other | Series C-1 Warrants | 68,244 | - | - | |
| Charles Larsen | Other | Series C-1 Warrants | 34,122 | - | - | |
| Charles Larsen | Other | Senior Secured Convertible Notes | 0 | - | - | |
| Charles Larsen | Other | Series A-1 Warrants | 34,122 | - | - | |
| Charles Larsen | Other | Series B-1 Warrants | 34,122 | - | - | |
| Dov Elefant - Officer | Other | Series A-1 Warrants | 34,122 | - | - | |
| Dov Elefant - Officer | Other | Series B-1 Warrants | 34,122 | - | - | |
| Dov Elefant - Officer | Other | Series C-1 Warrants | 34,122 | - | - | |
| Dov Elefant - Officer | Other | Senior Secured Convertible Notes | 0 | - | - | |
| Kathy Lee-Sepsick - Officer | Other | Common Stock | 48,535 | - | - | |
| Kathy Lee-Sepsick - Officer | Other | Common Warrants (right to buy) | 48,535 | - | - | |
| Dov Elefant - Officer | Other | Common Stock | 38,828 | - | - | |
| Dov Elefant - Officer | Other | Common Warrants (right to buy) | 38,828 | - | - | |
 Kelley Stinson Nicholas - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - |
FEMASYS INC (FEMY) had 9 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for FEMY runs to 26 Form 4 filings, the earliest from 2025-06-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
4 insider purchases of FEMY were filed in the last 90 days, totaling $124K.
No insider sales of FEMY were filed in the last 90 days.
This page tracks FEMY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add FEMY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
